Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Should You Be Taking NAC
In this population, 53% of individuals had commercial health insurance, 18% had Medicare, 11% had Medicaid, 1% had Dual (Medicare/Medicaid) coverage, and 17% had other coverage (e.g., Tricare, Veterans Affairs, or other State or local programs)
Paxlovid (nirmatrelvir/ritonavir) Disease area(s): Infectious diseases (antivirals) Manufacturer(s): Pfizer 2024 Sales (USD): $5.72 billion Why it sold so well: In 2024, Pfizers COVID-19 antiviral treatment, Paxlovid, generated $5.72 billion in global revenue, making it the companys third-highest-selling product for the year
We can change that
Reactions tend to be localized to application areas
US$ 29.21
US$ 29.75
US$ 20.63
US$ 29.84
